NCT02303522已完成不适用
A Retrospective Pooled Analysis of Complete Remission Among Pediatric Patients With Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 207
- 试验地点
- 1
- 主要终点
- Hematological Complete Remission (CR)
研究概览
简要总结
An historical data comparator study for children with relapsed/refactory acute lymphoblastic leukemia (ALL).
详细描述
A retrospective observational study reviewing historical complete remission for pediatric patients who had either relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL)
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Hematological Complete Remission (CR)
时间窗: Approx. 1 year
To estimate hematological Complete Remission (CR) in pediatric patients with relapsed or refractory B-cell precursor Acute Lymphoblastic Leukemia (ALL)
次要结局
- Time to hematological CR(Approx. 1 year)
- Overall survival(Approx. 1 year)
- Molecular CR(Approx. 1 year)
- Relapse Free Survival (RFS)(Approx. 1 year)
- Receipt of HSCT after salvage treatment(Approx. 1 year)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab ConsolidationAcute Lymphoblastic Leukemia, PediatricNCT05837689Xiaojun Xu20
已完成
不适用
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3Leukemia, AcuteNCT05969600Central Teaching Hospital of Peadiatrics, Baghdad521
已完成
不适用
Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology BranchLeukemia, Lymphoblastic, AcuteALL, ChildhoodNCT03627208National Cancer Institute (NCI)150
已完成
不适用
MRD Detection by NGS in Pediatric B-ALLAcute Lymphoblastic Leukemia, PediatricNCT05973032The Children's Hospital of Zhejiang University School of Medicine430
已完成
2 期
Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic LeukemiaAcute Lymphoblastic LeukemiaNCT02544789Betta Pharmaceuticals Co., Ltd.44